布洛芬在儿童中与发展或加剧喘的风险之间的关联:系统性审查和元分析
Luke Baxter1, Maria M Cobo2,3, Aomesh Bhatt2
1Department of Paediatrics, University of Oxford, Oxford, UK. luke.baxter@paediatrics.ox.ac.uk.
BMC pulmonary medicine
|August 26, 2024
概括
与其他药物相比,在儿童中使用布洛芬并没有增加喘风险. 然而,它可能会在患有喘的儿童中恶化喘症状,尽管长期影响尚不清楚.
科学领域:
- 儿科药理学 儿科药理学
- 呼吸系统医学 呼吸系统医学
- 系统审查是系统的审查.
背景情况:
- 布洛芬是一种常见的儿科止痛药和抗发烧药.
- 布洛芬在儿童喘发病过程中的作用尚不清楚.
- 本综述评估了布洛芬与儿童喘发展和恶化的关联.
研究的目的:
- 系统地审查有关儿童使用布洛芬及其与喘相关的证据.
- 为了评估在接受ibuprofen治疗的儿童中发展或加剧喘的风险.
主要方法:
- 在多个数据库 (MEDLINE,Embase等) 中进行全面的文献搜索. 截至 2022 年 5 月.
- 包括任何设计的24项同行评审研究,涉及0-18岁儿童.
- 根据PRISMA指南进行数据提取和偏差风险评估;发现的定量和定性综合.
主要成果:
- 与一般或喘儿童 (短期和长期) 的活跃比较者相比,与布洛芬相比,没有观察到喘风险的增加.
- 短期使用布洛芬可能会保护一般人群免受类似喘的症状,但可能会加剧已经存在的喘.
- 在这两个人群中都没有明确的长期对喘的影响.
结论:
- 在儿童中使用布洛芬并没有增加相对于活性比较剂的喘风险.
- 布洛芬可能会加剧患有喘的儿童的喘.
- 对于关键的临床上下文存在有限的研究,需要进一步的临床试验和观察性研究.
相关概念视频
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
230
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
230
Antiasthma Drugs: Leukotriene Modifiers
259
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
259
Antiasthma Drugs: β2-Adrenoceptor Agonists
241
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
241
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K


